BMI, body mass index; HIV, human immunodeficiency virus. Data are mean6standard deviation or n (%) unless otherwise specified. * Table 1 includes the primary analysis; all patients received the full course of the elected vaccine series at least 2 weeks before the start of the study period, with a cutoff date of May 30, 2021 (one dose for Janssen and two doses for mRNA vaccine). N for secondary analysis including both fully and partially vaccinated patients51,536. † Patients of the following races were specified as Other in the study database: American Indian, Asian, Indian (from India), Middle Eastern (Arabic), and Mixed Race. ‡ Vaccine type when including partial vaccinations: Pfizer n5996 (64.8); Moderna n5473 (30.7); Janssen n567 (4.3).

SMD, standardized mean difference; BMI, body mass index; HIV, human immunodeficiency virus. Data are mean6SD or n (%) unless otherwise specified. * Variable not included in propensity score matching model.

No abstract

No abstract